As part of IDA Foundation’s sustainability journey, our headquarters in Amsterdam were renovated in 2018 according to the highest green standards. As the area around our office is currently undergoing many changes, requiring our parking lot to be moved, IDA is taking the opportunity to also turn our office terrain into a climate-adaptive green zone that will benefit the local environment.
On Monday July 6, Johnson & Johnson announced a price reduction of the anti-tuberculosis medicine bedaquiline, for low- and middle-income countries. Thanks to the support of USAID and the Global Fund, this price reduction could be achieved. The price dropped from $400 to $340 for a six-month treatment regimen.
After months of working from home due to the major impact of the COVID-19 pandemic, we can say our staff does not take this as an excuse to stop exercising. The past few weeks our employees were challenged to share their ways of staying fit during this global crisis, with the very first IDA Fit Challenge. We asked colleagues to share how they are staying fit during lockdown.
The global supply chain is heavily impacted by the pandemic spread of the corona virus. Transport options are scarce due to export restrictions and due to countries being in lockdown to prevent the corona virus from further spreading. These regulations pose challenges for us as a supplier of medical goods.
As the Corona virus pandemic spreads around the globe, and all health care systems and governments seem to be engulfed with battling COVID-19, we realise it is more important than ever that we don’t lose sight of other existing health issues.
While coronavirus (COVID-19) dominates the news, we need to remember that another respiratory disease kills 1.5 million people per year: tuberculosis (TB). This is an opportunity to unite forces in the fight against TB and coronavirus.
With corona virus (COVID-19) spreading globally, IDA Foundation is closely monitoring the developments to ensure we are able to respond to any changes. This past week, we were glad to support the Asian Infrastructure Investment Bank (AIIB) by supplying medical goods to be used in the corona virus response in China.
As procurement agent for Stop TB /GDF, we are glad to share this news update as announced by the Stop TB partnership during the 50th Union Conference for Lung Health in Hyderabad, India.
This week (20-27 September) is Global Climate Strike week; also an opportunity for IDA Foundation to step up to support young climate strikers all over the world. Following earlier climate strikes these past years, this week has broken records with millions of people on the streets to take action for our climate. Today, our employees joined the climate strike by ‘striking’ outside our Amsterdam office.
World AIDS Day, held on 1 December every year since 1988, is an international day dedicated to creating awareness of the AIDS pandemic caused by the spread of HIV infection.
We are proud to share positive results from our partner, the USAID Global Health Supply Chain Program-Procurement and Supply Management project this week.
IDA Foundation attended the Portage Inaugural Meeting in Centro Sharjah, UAE. The meeting aims to discuss ways to simplify treatment and access for Children with Cancer in low and middle income countries.
On behalf of Stop TB Partnership’s Global Drug Facility (GDF), IDA Foundation (IDA), the GDF-contracted procurement agent, invites all eligible suppliers to submit bids (ITB) for 1st and 2nd line TB.
As we near the end of September, we look back at Childhood Cancer Awareness Month.
On Tuesday September 12th, IDA Foundation attended the official announcement of the Union World Conference on Lung Health in the Hague.
New edition of EML incorporates advice on use of antibiotics and adds medicines for Hepatitis C, HIV, TB and cancer.
This World Cancer Day, we answer your most frequently-asked questions about oncology medicines.
IDA Foundation has been hard at work with several partners creating a more modern, updated look for the IDA brand and website.
UICC initiative aims to improve cancer control in urbanized areas in LMICs by 2025.